Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-30 | Ms. Patil, 47, is a new director nominee. Since February 2021, she has held the position of Chief Legal Officer and Senior Vice President, Legal and Corporate Affairs of Jazz Pharmaceuticals plc, a biopharmaceutical company. ... Ms. Patil's executive and senior management experience in the healthcare industry will enable her to provide valuable insights regarding a wide range of business matters, including commercial matters, operations, acquisitions and strategic planning initiatives. ... Ms. Patil's legal background renders her particularly well qualified to assist the Board in addressing a variety of public company, board governance and public policy matters, as well as helping to provide oversight regarding our ESG programs. |
| 2023-03-31 | Ms. Patil, 48, has been a director of Teleflex since 2022 and currently serves as a member of the Nominating and Governance Committee. ... The table below summarizes the compensation paid to non-management directors during the fiscal year ended December 31, 2022. ... Nina M. Patil $55,333 Fees Earned Or Paid in Cash, $113,384 Stock Awards, $148,469 Option Awards, Total $317,186. |
| 2025-03-28 | Since February 2021, she has held the position of Chief Legal Officer and Executive Vice President of Jazz Pharmaceuticals plc. |
Data sourced from SEC filings. Last updated: 2025-08-30